NCT04219254 2026-04-15
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
BioInvent International AB
Phase 1/2 Recruiting
BioInvent International AB
University Hospital, Geneva
Centre Oscar Lambret
ImmunOs Therapeutics AG
DualityBio Inc.
3D Medicines
CytomX Therapeutics
Accession Therapeutics Limited
CytomX Therapeutics
BioCytics, Inc.
Akeso
GenVivo, Inc.
University of Oklahoma
Ion Beam Applications
BeOne Medicines
Kumquat Biosciences Inc.
Masonic Cancer Center, University of Minnesota
Grit Biotechnology
CytoDyn, Inc.